Opioid abuse with opioid-induced psychotic disorder with delusions
ICD-10 F11.150 is a billable code used to indicate a diagnosis of opioid abuse with opioid-induced psychotic disorder with delusions.
F11.150 refers to a condition characterized by the abuse of opioids leading to a psychotic disorder, specifically manifesting as delusions. Opioid abuse is a significant public health concern, often resulting in severe psychological and physical health issues. Individuals with this diagnosis typically exhibit a pattern of compulsive opioid use despite harmful consequences. The psychotic disorder is a direct result of the substance use, where the individual experiences delusions—fixed false beliefs that are resistant to reason or confrontation with actual fact. These delusions can significantly impair social and occupational functioning and may require immediate intervention. Treatment often involves a combination of pharmacotherapy, such as the use of methadone or buprenorphine, and psychosocial support, including cognitive-behavioral therapy. The complexity of this diagnosis lies in the need for comprehensive assessment and management of both the substance use disorder and the associated psychotic symptoms.
Detailed psychiatric evaluations, including mental status exams and history of substance use.
Patients presenting with acute psychosis following opioid use, or those with chronic opioid use and worsening mental health.
Consideration of the patient's overall mental health history and potential for dual diagnosis.
Comprehensive substance use history, including types of opioids used, duration, and impact on daily functioning.
Patients in withdrawal experiencing psychotic symptoms or those in treatment programs showing signs of relapse.
Integration of behavioral health interventions with pharmacotherapy for effective treatment.
Used in conjunction with substance use counseling for patients with opioid use disorder.
Document the counseling session details and patient response.
Important for addiction specialists to integrate smoking cessation into treatment.
F11.150 is used when the patient exhibits delusions as part of their opioid-induced psychotic disorder, while F11.149 is used when there are psychotic symptoms without delusions.
